Form 4: Axon Enterprise CPO & CTO, Jeffrey C. Kunins, Executes Stock Transactions
SEC Form 4 Filing
Axon Enterprise's Chief Product and Technology Officer, Jeffrey C. Kunins, sold a portion of his shares to cover tax obligations and pursuant to a pre-arranged trading plan.
Summary
- Jeffrey C. Kunins, the Chief Product and Technology Officer of Axon Enterprise, Inc., engaged in multiple transactions involving the company's common stock.
- On December 2, 2024, Mr. Kunins disposed of 1,167 shares at $646.96 and 330 shares at $636.39 to cover tax liabilities from vesting restricted stock units.
- Between December 3 and December 4, 2024, Mr. Kunins sold a total of 2,837 shares at various prices ranging from $642.92 to $673.00, as part of a pre-arranged Rule 10b5-1 trading plan.
- Following these transactions, Mr. Kunins directly owns 128,209 shares of Axon Enterprise common stock.
Sentiment
Score: 5
Explanation: The document reflects routine transactions by an executive, with no indication of positive or negative sentiment. The sales are part of a pre-arranged plan and tax obligations, which is a neutral event.
Risks
- The sale of shares by a high-ranking executive could be perceived negatively by some investors, potentially impacting the stock price.
- The reliance on a pre-arranged trading plan may indicate a lack of confidence in the company's short-term prospects by the executive, although this is not necessarily the case.
Industry Context
Executive stock transactions are a common occurrence in publicly traded companies. These transactions are often part of compensation packages or personal financial planning. The use of a Rule 10b5-1 plan is a standard practice to avoid accusations of insider trading.
Comparison to Industry Standards
- The use of Rule 10b5-1 trading plans is a common practice among executives at publicly traded companies, including those in the technology sector like Axon.
- Companies such as Motorola Solutions and Digital Ally, which also operate in the public safety technology space, often see similar filings from their executives.
- The volume of shares sold is not unusual for an executive at this level, and the prices are within the typical trading range for Axon stock.
Stakeholder Impact
- The transactions may have a minor impact on shareholder sentiment, but the pre-planned nature of the sales should mitigate any significant concerns.
- The sales do not directly impact employees, customers, suppliers, or creditors.
Key Dates
| Date | Description |
|---|---|
| 05/15/2024 | Date the Rule 10b5-1 trading plan was adopted by the reporting person. |
| 12/02/2024 | Date of initial share disposals to cover tax liabilities. |
| 12/03/2024 | Date of multiple share sales under the Rule 10b5-1 trading plan. |
| 12/04/2024 | Date of final share sale under the Rule 10b5-1 trading plan and date of filing. |
Keywords
Axon Enterprise, Jeffrey C. Kunins, stock sale, Rule 10b5-1, insider trading, executive compensation, share disposal, CPO, CTO
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.